Zeo ScientifiX (ZEOX) Cash from Operations (2012 - 2026)
Zeo ScientifiX (ZEOX) posted quarterly Cash from Operations of 138000.0 for Q2 2026, up 3.5% year-over-year from 133337.84 in Q2 2025, and up 70.7% quarter-over-quarter from 471000.0 in Q1 2026.
Zeo ScientifiX (ZEOX) Cash from Operations (2012 - 2026) Analysis & Trends
Zeo ScientifiX's Cash from Operations history runs 14 years deep, the most recent figure standing at 138000.0 for Q2 2026.
- In Q2 2026, Cash from Operations rose 3.5% year-over-year to 138000.0; the TTM figure through Apr 2026 stood at 1249000.0 (down 132.16% YoY), while the FY2025 annual figure was 718000.0, up 50.48% from the prior year.
- Cash from Operations for Q2 2026 stood at 138000.0, up from 471000.0 in the prior quarter.
- The five-year high for Cash from Operations was 221000.0 in Q4 2023, with the low at 1757597.0 in Q4 2022.
- The 5-year median for Cash from Operations is 399000.0 (2024), against an average of 452213.33.
- Peak annual rise in Cash from Operations reached 112.57% in 2023, while the deepest fall reached 949.27% in 2023.
- Zeo ScientifiX's Cash from Operations stood at 1757597.0 in 2022, then soared by 112.57% to 221000.0 in 2023, then sank by 265.61% to 366000.0 in 2024, then retreated by 4.64% to 383000.0 in 2025, then surged by 63.97% to 138000.0 in 2026.
- Business Quant data shows ZEOX's Cash from Operations at 138000.0 in Q2 2026, 471000.0 in Q1 2026, and 383000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn | -138,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -138,000.00 |
| Apr 30, 2026 | -138,000.00 |
| Jan 31, 2026 | -471,000.00 |
| Jan 31, 2026 | -471,000.00 |
| Oct 31, 2025 | -383,000.00 |
| Oct 31, 2025 | -383,000.00 |
| Jul 31, 2025 | -257,000.00 |
| Jul 31, 2025 | -257,000.00 |
| Apr 30, 2025 | -143,000.00 |
| Apr 30, 2025 | -143,000.00 |
| Jan 31, 2025 | 65,000.00 |
| Jan 31, 2025 | 65,000.00 |
| Oct 31, 2024 | -366,000.00 |
| Oct 31, 2024 | -366,000.00 |
| Jul 31, 2024 | -94,000.00 |
| Jul 31, 2024 | -94,000.00 |
| Apr 30, 2024 | -415,000.00 |
| Apr 30, 2024 | -415,000.00 |
| Jan 31, 2024 | -575,000.00 |
| Jan 31, 2024 | -575,000.00 |